Physician profile
Charles Adam Decook
NPI 1386794113
$48,346,319.25
in general payments reported to CMS, 2019-2025
37 companies · $3.2M in 2025
The $3.2M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5.9M · 2020: $1.2M · 2021: $1.3M · 2022: $10M · 2023: $134K · 2024: $26M · 2025: $3.2M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $29M · Education: $386K · Consulting Fee: $184K · Royalty Or License: $125K · Travel and Lodging: $40K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Food and Beverage: $17K · Long Term Medical Supply Or Device Loan: $2,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $28,813,558.36 |
| Education | $385,645.36 |
| Consulting Fee | $183,846.22 |
| Royalty Or License | $125,259.65 |
| Travel and Lodging | $39,939.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,722.00 |
| Food and Beverage | $16,813.73 |
| Long Term Medical Supply Or Device Loan | $2,459.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $45,557,608.41 | 2019-2025 | |
| Medical Device Business Services, INC. | $1,832,659.45 | 2019-2024 | Kincise, Attune, Actis |
| Zimmer Biomet Holdings, INC. | $658,604.24 | 2019-2025 | G7, Persona, Avenir |
| Medtronic, INC. | $110,579.41 | 2021-2024 | Aquamantys(Tm) |
| Medtronic USA, INC. | $108,450.25 | 2019-2020 | |
| Canary Medical USA LLC | $69,400.00 | 2024 | |
| Depuy Synthes Sales INC. | $3,938.78 | 2019-2024 | Corail, Actis, Attune |
| Smith+Nephew, INC. | $1,002.25 | 2019-2025 | Real Intelligence, Journey II, Pico 14 |
| Ethicon US, LLC | $675.00 | 2021 | |
| Medacta USA, INC. | $579.53 | 2022-2024 | Gmk Sphere |
| Microport Orthopedics INC | $492.98 | 2022-2023 | Mpo Medial Pivot Knee |
| Ethicon INC. | $485.88 | 2022 | |
| Linkbio Corp | $184.80 | 2024 | |
| Heron Therapeutics, INC. | $168.63 | 2025 | Zynrelef |
| Abbott Laboratories | $164.32 | 2024 | Proclaim |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $158.87 | 2019-2021 | |
| Becton, Dickinson and Company | $157.82 | 2024 | Arista Ah Flexitip |
| Stryker Corporation | $132.54 | 2025 | |
| Next Science LLC | $113.73 | 2021-2024 | Blastx, Surgx, Xperience |
| Encore Medical, Lp | $108.79 | 2019 | |
| Uoc USA INC | $95.00 | 2019 | |
| Curonix LLC | $90.81 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Heraeus Medical, LLC. | $89.23 | 2019-2020 | |
| Horizon Therapeutics Plc | $60.33 | 2019 | |
| Davol INC. | $41.30 | 2025 | |
| Osteoremedies, LLC | $38.28 | 2022 | |
| Pfizer INC. | $38.06 | 2019 | |
| Acacia Pharma INC | $33.83 | 2021 | |
| Mallinckrodt Enterprises LLC | $27.01 | 2019 | |
| Boston Scientific Corporation | $24.26 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $22.11 | 2024 | Zilretta, Iovera, Exparel |
| Cumberland Pharmaceuticals, INC. | $18.78 | 2019 | |
| Steris Corporation | $18.12 | 2024 | |
| Convatec INC. | $15.67 | 2019 | |
| Kuros Biosciences USA, INC | $15.11 | 2023 | |
| Access Pro Medical, LLC | $14.37 | 2025 | Matriderm |
| Ferring Pharmaceuticals INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Decook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.